Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Grasping Various Kinds of Local misdemeanors - 2Antivirus Programming for Exhaustive Security
- 3Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- 4This Is Canada's Only Province Without Any Bears
- 5The Most Famous Virtual Entertainment Powerhouses of the Year
- Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- Colombia's military rescues 6 siblings who hid in the rainforest to escape from a rebel group
- To fix a patient's irregular heartbeat, doctors first tested its digital 'twin'
- Historic underwater structure discovered by divers off French coast
- Melodic Combination d: A Survey of \Unrecorded Music Energy\ Show
- 10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide
- Gaza receiving over 70,000 cubic meters of water per day, COGAT claims
- Find Serenity: 10 Stunning Setting up camp Areas
- Space station changes command, setting stage for Crew 11 departure
